LABORATORIOS FARMACEUT./ ES0157261019 /
2024-11-15 8:58:28 PM | Chg. -2.85 | Volume | Bid9:59:59 PM | Ask9:59:59 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
62.15EUR | -4.38% | 339 Turnover: 21,110.45 |
62.05Bid Size: 50 | 62.30Ask Size: 50 | 3.36 bill.EUR | 2.08% | 19.42 |
Assets
|
2022 IFRS in th. EUR |
2023 IFRS in th. EUR |
|||
---|---|---|---|---|---|
Property and Equipment | 215,541 | 253,652 | |||
Intangible Assets | 35,744 | 33,902 | |||
Long-Term Investments | 2,202 | 591 | |||
Fixed Assets | 255,630 | 290,553 | |||
Inventories | 311,944 | 337,968 | |||
Accounts Receivable | 180,011 | 143,314 | |||
Cash and Cash Equivalents | 124,945 | 25,322 | |||
Current Assets | 623,073 | 509,331 | |||
Total Assets | 878,703 | 799,884 |
Liabilities
|
2022 IFRS in th. EUR |
2023 IFRS in th. EUR |
|||
---|---|---|---|---|---|
Accounts Payable | 165,776 | 141,895 | |||
Long-term debt | 59,441 | 52,242 | |||
Liabilities to Banks | - | - | |||
Provisions | 677 | 1,515 | |||
Liabilities | 357,324 | 256,390 | |||
Share Capital | - | - | |||
Total Equity | 520,012 | 539,387 | |||
Minority Interests | 1,367 | 4,107 | |||
Total liabilities equity | 878,703 | 799,884 |
Income Statement
|
2022 IFRS in th. EUR |
2023 IFRS in th. EUR |
|||
---|---|---|---|---|---|
Revenues | 817,698 | 829,509 | |||
Depreciation (total) | 22,871 | 24,331 | |||
Operating Result | 255,848 | 220,254 | |||
Interest Income | 921 | 556 | |||
Income Before Taxes | - | - | |||
Income Taxes | 58,302 | 50,109 | |||
Minority Interests Profit | -4 | -36 | |||
Net Income | 199,669 | 170,335 |
Per Share
Cash Flow
|
2022 IFRS in th. EUR |
2023 IFRS in th. EUR |
|||
---|---|---|---|---|---|
Cash Flow from Operating Activities | 237,602 | 113,247 | |||
Cash Flow from Investing Activities | -57,154 | -52,028 | |||
Cash Flow from Financing | -154,538 | -160,842 | |||
Decrease / Increase in Cash | - | - | |||
Employees | 1,993 | 2,111 |